Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2019-11-12 Other | 2019-11-15 8:02 pm | N/A N/A | Dova Pharmaceuticals Inc. | DOVA | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD EDELMAN JOSEPH 10% Owner | 3,125,851 | $0 | 3,125,851 (Indirect) | View |
| 2019-11-12 Disposition | 2019-11-12 4:42 pm | N/A 2018-12-18 | Dova Pharmaceuticals Inc. | DOVA | ZACCARDELLI DAVID President & CEO | 1,076,647 | $0 | 0 (Direct) | View |
| 2019-11-12 Disposition | 2019-11-12 4:41 pm | N/A 2029-04-25 | Dova Pharmaceuticals Inc. | DOVA | Wysenski Nancy Director | 16,274 | $0 | 0 (Direct) | View |
| 2019-11-12 Equity Swap | 2019-11-12 4:40 pm | N/A N/A | Dova Pharmaceuticals Inc. | DOVA | Stalfort Sean Director | 635,665 | $27.5 | 0 (Direct) | View |
| 2019-11-12 Disposition | 2019-11-12 4:39 pm | N/A 2027-05-24 | Dova Pharmaceuticals Inc. | DOVA | Novak Alfred J Director | 49,901 | $0 | 0 (Direct) | View |
| 2019-11-12 Equity Swap | 2019-11-12 4:38 pm | N/A N/A | Dova Pharmaceuticals Inc. | DOVA | Manning Paul B Director 10% Owner | 14,762,242 | $27.5 | 0 (Direct) | View |
| 2019-11-12 Disposition | 2019-11-12 4:37 pm | N/A 2027-03-27 | Dova Pharmaceuticals Inc. | DOVA | Laliberte Kevin Sr. VP, Product Development | 205,011 | $0 | 0 (Direct) | View |
| 2019-11-12 Disposition | 2019-11-12 4:36 pm | N/A 2027-05-24 | Dova Pharmaceuticals Inc. | DOVA | JEFFS ROGER Director | 109,993 | $0 | 0 (Direct) | View |
| 2019-11-12 Disposition | 2019-11-12 4:35 pm | N/A 2028-12-18 | Dova Pharmaceuticals Inc. | DOVA | Hoitt Jason Chief Commercial Officer | 259,970 | $0 | 0 (Direct) | View |
| 2019-11-12 Disposition | 2019-11-12 4:34 pm | N/A 2028-10-07 | Dova Pharmaceuticals Inc. | DOVA | Hahn Mark W Chief Financial Officer | 309,024 | $0 | 0 (Direct) | View |
| 2019-11-12 Disposition | 2019-11-12 4:33 pm | N/A 2027-05-24 | Dova Pharmaceuticals Inc. | DOVA | Goldman Steven M. Director | 167,696 | $0 | 0 (Direct) | View |
| 2019-11-12 Disposition | 2019-11-12 4:32 pm | N/A 2027-04-13 | Dova Pharmaceuticals Inc. | DOVA | ALLEN LEE F MD PhD Chief Medical Officer | 271,101 | $0 | 0 (Direct) | View |